As shown in Figure 1E, although patients with breast invasive carcinoma (BRCA) from the TCGA database with high and low/medium FSTL1 expression had the same survival rate before 4000 days, they seemed to have a better survival rate over a more extended period. Here, FSTL1 is linked to invasive breast carcinoma.